

          -  Patients with known history of serious allergic reactions, including anaphylaxis, to
             any of the study medications, or any component of the product.

          -  mechanical ventilation > 24 h at randomization

          -  clinical frailty scale above 2

          -  active bacterial or fungal infection

          -  unlikely to survive beyond 48h

          -  neutrophil count below 1500 cells/microliter

          -  platelets below 50.000/microliter

          -  Patients enrolled in another investigational drug study

          -  patients on high dose systemic steroids (> 20 mg methylprednisolone or equivalent) for
             COVID-19 unrelated disorder

          -  patients on immunosuppressant or immunomodulatory drugs

          -  patients on current anti-IL1 or anti-IL6 treatment

          -  signs of active tuberculosis

          -  serum transaminase levels >5 times upper limit of normal

          -  bowel perforation or diverticulitis

          -  pregnant or breastfeeding females (all female subjects deemed of childbearing
             potential by the investigator must have negative pregnancy test at screening)
      